Evald Høj Christiansen

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. doi Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
    Evald Høj Christiansen
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    Lancet 381:661-9. 2013
  2. ncbi Transient coronary aneurysm formation after Nevo™ stent implantation versus persistent coronary aneurysm after Cypher Select™ stent implantation
    Evald Høj Christiansen
    Department of Cardiology, University of Aarhus, Skejby Hospital, Denmark
    J Invasive Cardiol 23:E158-60. 2011
  3. doi Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Am J Cardiol 109:629-35. 2012
  4. doi Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark Electronic address
    Lancet 383:2047-56. 2014
  5. doi Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 110:1585-91. 2012
  6. doi 2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    J Am Coll Cardiol 60:1140-7. 2012
  7. doi Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Circulation 125:1246-55. 2012
  8. pmc Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
    Troels Thim
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
    BMC Cardiovasc Disord 12:18. 2012
  9. doi Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial
    Lisette Okkels Jensen
    From the Department of Cardiology, Odense University Hospital, Denmark L O J, P T, A J, K T V, K N H, H S H Department of Cardiology, Aarhus University Hospital, Skejby, Denmark M Maeng, L R K, C J T, A K, S D K, H E B, J F L, E H C Department of Cardiology, Aalborg University Hospital, Denmark J R, B R, A B V, H H T, J A, S E J and Department of Clinical Epidemiology, Aarhus University, Denmark M Madsen, K B
    Circ Cardiovasc Interv 9:. 2016
  10. doi Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 83:864-72. 2014

Collaborators

Detail Information

Publications26

  1. doi Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
    Evald Høj Christiansen
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    Lancet 381:661-9. 2013
    ..We aimed to further investigate the effects of a biodegradable polymer biolimus-eluting stent compared with a durable polymer-coated sirolimus-eluting stent in a population-based setting...
  2. ncbi Transient coronary aneurysm formation after Nevo™ stent implantation versus persistent coronary aneurysm after Cypher Select™ stent implantation
    Evald Høj Christiansen
    Department of Cardiology, University of Aarhus, Skejby Hospital, Denmark
    J Invasive Cardiol 23:E158-60. 2011
    ..We hypothesize that aneurysm formation was induced by sirolimus and the polymer of the implanted stents, and that subsequent healing was possible in the Nevo stent after degradation of the polymer...
  3. doi Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Am J Cardiol 109:629-35. 2012
    ..03, 95% CI 1.59 to 2.59). In conclusion, stent thrombosis rate was similar in patients with and without DM and STEMI treated with primary PCI, whereas the presence of DM increased the risk of MI, TLR, and death...
  4. doi Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark Electronic address
    Lancet 383:2047-56. 2014
    ..However, the optimum timepoint for this assessment remains unclear. In this study, we assessed clinical outcomes at up to 5 years' follow-up in patients who received two different types of drug-eluting stents...
  5. doi Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 110:1585-91. 2012
    ..In conclusion, patients with diabetes have higher MACE rates than nondiabetics. No significant differences in safety or efficacy outcomes after EES or SES implantation were present in nondiabetic or diabetic patients...
  6. doi 2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    J Am Coll Cardiol 60:1140-7. 2012
    ..There are limited head-to-head randomized data on patient-related versus stent-related outcomes for everolimus-eluting stents (EES) and sirolimus-eluting stents (SES)...
  7. doi Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Circulation 125:1246-55. 2012
    ..Among drug-eluting stents released to date, the sirolimus-eluting stent has demonstrated the least amount of late lumen loss, but its efficacy and safety have not been compared head-to-head with the next-generation everolimus-eluting stent...
  8. pmc Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
    Troels Thim
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
    BMC Cardiovasc Disord 12:18. 2012
    ..However, a separate comparison of clinical outcome among patients treated for multiple lesions with these stents is lacking. We performed this comparison within the SORT OUT III trial data set...
  9. doi Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial
    Lisette Okkels Jensen
    From the Department of Cardiology, Odense University Hospital, Denmark L O J, P T, A J, K T V, K N H, H S H Department of Cardiology, Aarhus University Hospital, Skejby, Denmark M Maeng, L R K, C J T, A K, S D K, H E B, J F L, E H C Department of Cardiology, Aalborg University Hospital, Denmark J R, B R, A B V, H H T, J A, S E J and Department of Clinical Epidemiology, Aarhus University, Denmark M Madsen, K B
    Circ Cardiovasc Interv 9:. 2016
    ..Coronary drug-eluting stents with biodegradable polymers have been designed to improve safety and efficacy...
  10. doi Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 83:864-72. 2014
    ..To evaluate the effects of the everolimus-eluting Xience™/Promus™ stent (EES) and the sirolimus-eluting Cypher™ stent (SES) on intimal hyperplasia (IH) in diabetic patients...
  11. pmc Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark
    BMC Cardiovasc Disord 12:84. 2012
    ..We evaluated the effectiveness and safety of a zotarolimus-eluting (ZES) versus a sirolimus-eluting (SES) coronary stent in a large cohort of patients treated with one of these stents in Western Denmark...
  12. pmc Staged re-evaluation of non-culprit lesions in ST segment elevation myocardial infarction: a retrospective study
    Troels Thim
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
    Open Heart 3:e000427. 2016
    ....
  13. doi Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
    Klaus Rasmussen
    Department of Cardiology, Aarhus University Hospital, Aalborg Hospital, Aalborg, Denmark
    Lancet 375:1090-9. 2010
    ..We compared the efficacy and safety of the zotarolimus-eluting stent versus the sirolimus-eluting stent in patients with coronary artery disease who were receiving routine clinical care with no direct follow-up...
  14. doi 3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    JACC Cardiovasc Interv 5:812-8. 2012
    ....
  15. doi A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial)
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    Catheter Cardiovasc Interv 86:1161-7. 2015
    ..We aimed to compare angiographic and clinical outcomes after the implantation of everolimus-eluting (EES) and sirolimus-eluting (SES) stents in patients with diabetes...
  16. doi Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial
    Per Thayssen
    From the Department of Cardiology, Odense University Hospital, Odense, Denmark P T, K N H, H S H, A J, K T V, L O J Department of Cardiology, Aarhus University Hospital, Skejby, Denmark J F L, E H C, L T and Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark S E J, J R
    Circ Cardiovasc Interv 7:216-24. 2014
    ..We compared the risk of acute CIN and the influence of preventive strategies in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention...
  17. doi Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial
    Anne Kaltoft
    Department of Cardiology B, Aarhus University Hospital, Skejby, 8200, Aarhus N, Denmark
    J Nucl Cardiol 16:784-91. 2009
    ..In a prospective randomized trial, we assessed the effect of routine filterwire distal protection on scintigraphic estimated infarct size...
  18. doi Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction)
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 108:1395-400. 2011
    ..Patients with SAP had the lowest mortality rates and rates of clinically driven target vessel revascularization decreased over time...
  19. doi Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial
    Hans Erik Bøtker
    Department of Cardiology, Aarhus University Hospital Skejby, Aarhus N, Denmark
    Lancet 375:727-34. 2010
    ..We tested the hypothesis that remote ischaemic conditioning during evolving ST-elevation myocardial infarction, and done before primary percutaneous coronary intervention, increases myocardial salvage...
  20. pmc Evaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary intervention
    Gro Egholm
    Department of Cardiology Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus
    Clin Epidemiol 8:415-423. 2016
    ..Registry-based monitoring of the safety and efficacy of interventions in patients with ischemic heart disease requires validated algorithms...
  21. doi Co-registration of optical coherence tomography and X-ray angiography in percutaneous coronary intervention. the Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) fusion study
    Lasse Hebsgaard
    Department of Cardiology, Aarhus University Hospital, Skejby, Denmark
    Int J Cardiol 182:272-8. 2015
    ..During percutaneous coronary intervention (PCI), it may be challenging to identify corresponding segments between intracoronary imaging and angiography. Computer based online co-registration may aid the target segment identification...
  22. ncbi Coronary artery bypass surgery in heart failure patients with chronic reversible and irreversible myocardial dysfunction: effect on heart rate variability
    Henrik Wiggers
    Department of Cardiology, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark
    Cardiology 98:181-5. 2002
    ..A potential prognostic benefit gained by revascularizing patients with viability may occur in spite of deteriorated autonomic control of heart rate...
  23. pmc ST Elevation Infarction after Heart Transplantation Induced by Coronary Spasms and Mural Thrombus Detected by Optical Coherence Tomography
    Tor Skibsted Clemmensen
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
    Case Rep Transplant 2016:1863869. 2016
    ..The patient was stabilized after percutaneous coronary intervention. As a mural thrombus often goes undetected by coronary angiography, OCT may prove benefit in HTx patients with myocardial infarction or suspected coronary spasms...
  24. pmc Prosthetic valve endocarditis after transcatheter aortic valve implantation-diagnostic and surgical considerations
    Khalil Ahmad
    Department of Cardiothoracic and Vascular Surgery, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
    J Thorac Dis 8:E1213-E1218. 2016
    ..We report a case of TAVI-PVE in an 80-year-old high risk patient in whom SAVR was successfully performed. We have reviewed literature regarding TAVI-PVE...
  25. doi The Impella CP device for acute mechanical circulatory support in refractory cardiac arrest
    Henrik Vase
    Department of Cardiology, Aarhus University Hospital, Denmark Electronic address
    Resuscitation . 2016
    ..Animal studies suggest a potential role for the Impella® left ventricular assist device in this setting, but so far no human data have been published...
  26. ncbi Takotsubo cardiomyopathy. An important differential diagnosis to acute myocardial infarction
    Lene Hüche Nielsen
    Department of Cardiology, Vejle Hospital, DK 7100 Vejle, Denmark
    Dan Med Bull 56:165-8. 2009
    ..The purpose of this study was to describe the clinical characteristics and electrocardiographic changes in a Danish cohort of patients with TC. We discuss the potential pathophysiological mechanisms of TC...